openPR Logo
Press release

Sarcopenia Treatment Market Revenue to close to US$ 3.30 Bn with CAGR of 4.2% by 2026

08-08-2022 07:56 AM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Sarcopenia Treatment Market 2022

Sarcopenia Treatment Market 2022

Sarcopenia Treatment Market 2022

Global Sarcopenia Treatment Market to Witness High Revenue Growth in North America Followed by Europe: Persistence Market Research.

According to the latest market report published by the company titled 'Sarcopenia Treatment Market: Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2026,' the global sarcopenia treatment market is projected to reach US$ 3,302.0 Mn by the end of 2026 and grow at a CAGR of 4.2% during the forecast period.

Get Free Sample Copy Of Sarcopenia Treatment Market Report@ https://www.persistencemarketresearch.com/samples/15694

Company Profiles:

At Abbott Laboratories
Pfizer Inc.
Novartis AG
GlaxoSmithKline Plc.
Nestle SA
Bayer AG
Sanofi S.A.
Amway
Cadila Healthcare Ltd.
Eli Lilly and Company

Global Sarcopenia Treatment Market: Dynamics

Sarcopenia is categorized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 the muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia among people aged 65 years and above is estimated to be 15%, whereas 50% among people aged 80 and above.

Increasing consumption of dietary and nutritional supplements due to health consciousness among the elderly population is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiency is expected to boost the growth of the sarcopenia treatment market. Most of the pharmaceutical and food-processing companies are investing in the development of new nutrition supplements in order to focus on the specific needs. Likewise, increasing investments in nutraceutical development is the major factor expected to spur the growth of the sarcopenia treatment market. The growth of the sarcopenia treatment market is primary driven by the increasing aging population.

Look Through The "Methodology" Employed@ https://www.persistencemarketresearch.com/methodology/15694

According to the National Institutes of Health (NIH), the global population of people aged 80 and above is expected to grow from 126.5 million to 446.6 million between 2015 and 2050. Reduction of hormone secretion rate and increasing vitamin deficiency with aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as the rise in consumer spending by the aging population and increasing per capita healthcare expenditure are also expected to drive the demand for sarcopenia treatment supplements. According to the National Health Expenditure Accounts (NHEA), the U.S. health care spending grew by 4.3% in 2016, reaching US$ 3.3 trillion or US$ 10,348 per person.

However, the diagnosis rate of sarcopenia is very low as a large number of people ignore the symptoms of muscle loss. Moreover, low awareness regarding diagnostic and management methods of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market. Moreover, unavailability of sarcopenia treatment drugs and the high cost of protein supplement are the other factors expected to restrain the growth of the sarcopenia treatment market.

Global Sarcopenia Treatment Market: Forecast

The global sarcopenia treatment market is segmented based on treatment type, distribution channel, and region. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin D & calcium supplement, and vitamin B12 supplement. The protein supplement segment is expected to represent a high revenue share in the global sarcopenia treatment market over the forecast period.

Based on the distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket & supermarket. Among all the distribution channels, the retail pharmacies is expected to be the leading segment in the global sarcopenia treatment market over the forecast period. The online pharmacies segment is expected to represent a high growth rate in the global sarcopenia treatment market due to increasing online purchasing and manufacturer's inclination towards digital platforms for marketing and sale.

On the basis of region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the sarcopenia treatment in specific regions. North America is expected to contribute a high revenue share in the global sarcopenia treatment market over the forecast period. The demand for sarcopenia treatment has increased in North America due to the increasing adoption of nutritional supplements, particularly by the elderly population due to increasing health consciousness.

Europe is expected to account second large share in the global sarcopenia treatment market over the forecast period. The developed European countries, such as Germany, the U.K., France, and Italy, are expected to account high share in the Europe sarcopenia treatment market due to increasing sarcopenia prevalence associated with inactive lifestyle and obesity. The Asia Pacific is expected to witness rapid growth in the global sarcopenia treatment market over the forecast period due to increasing aging population in countries such as Japan.

Purchase Our Sarcopenia Treatment Market Report Now@ https://www.persistencemarketresearch.com/checkout/15694

Key Questions Answered in This Report.

What will the Market growth rate in Future?
What are the key factors driving the global Market?
Who are the key manufacturers in Market space?
What are the opportunities and threats faced by the vendors in the global industry?
What are sales, revenue, and price analysis by regions of industry?

Related Reports-

Heel Pressure Injury Relieving Devices Market - https://www.persistencemarketresearch.com/market-research/heel-pressure-injury-relieving-devices-market.asp

Therapeutic Vaccines Market - https://www.persistencemarketresearch.com/market-research/therapeutic-vaccines-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us: 

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sarcopenia Treatment Market Revenue to close to US$ 3.30 Bn with CAGR of 4.2% by 2026 here

News-ID: 2699886 • Views: 201

More Releases from Persistence Market Research

Construction Chemicals Market is Projected to reach a market value of US$ 21.6 B …
Construction Chemicals Market 2022 As per Persistence Market Research analysis, the construction chemicals market is projected to reach a market value of US$ 21.6 Bn in 2031, expanding at an impressive CAGR of close to 14% over the forecast period of 2021-2031. Request For Free Sample Report of Construction Chemicals Market @https://www.persistencemarketresearch.com/samples/22522 The analysis includes forecasted Construction Chemicals Market valuation and growth rate, as per the researchers' review. This India Construction Chemicals Market
Mosquito Repellents Market is expected to touch a US$ 10.6 Bn by the end of 2026
Mosquito Repellents Market 2022 The global mosquito repellent market is estimated to reach a value of over US$ 10,689.6 Mn by the end of 2026 while registering a CAGR of 8.0% between 2018 and 2026. Mosquito Repellents Volume Sales to Exceed 54,406 Mn Units in 2022. Request for Free Sample Copy of Mosquito Repellents Market Report@https://www.persistencemarketresearch.com/samples/25825 Environmental changes such as land-surface characteristics and variation in climate, along with increased anthropogenic activities comprising mining,
Caster Wheels Market Projection By Technology, Top Key Players, Demand, Segment, …
Caster Wheels Market 2022 According to a study, in 2015, injuries related to material handling cost business stood at $14.2 billion in direct expenses. Moreover, it was estimated that 10% of major back injuries in the industry are associated with pulling or pushing tasks. Therefore, due to the aforementioned reasons, the demand for caster wheels has increased over the years. Request for Free Sample Copy of Caster Wheels Market Report@https://www.persistencemarketresearch.com/samples/23782 Moving bulky items
Pressure Washer Market SWOT Analysis of Top Key Player Forecasts to 2031| Snow J …
Pressure Washer Market 2022 Pressure water manufacturers are focused on building advanced products catering to the need of end users. For instance, products with in-built water filter preventing dust and derbis from entering the pump, a pressure switch enabling automatic motor, and compact and light weight among others. For instance factors such as power output, water flow rate, weight, water pressure and accessories availability with the pressure washer are key essentials for

All 5 Releases


More Releases for Sarcopenia

The Sarcopenia Treatment Market to be digitally servile
The Sarcopenia Treatment Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent
Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026
The report published on the “Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026” by Zion Market Research facilitates a closer outlook on opportunities, revenue growth, and current market trends. The report is focused to offer qualitative and quantitative analysis of dynamics and market opportunities prevailing during the forecast period. Also, the report encompasses an in-depth study on the prominent leaders in the Sarcopenia Market. The Leading Market Players Covered
Sarcopenia Treatment Market to Witness Significant Incremental Opportunity
According to a recent report published by Research Dive, titled, "Sarcopenia Treatment Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global Sarcopenia Treatment market size was valued at $ 2742.4 million in 2018, and is projected to reach $ 3975.0 million by 2026, registering a CAGR of 4.7% from 2018 to 2026. North America dominates the market, followed by Europe, Asia-Pacific, Latin America, Middle East and
Sarcopenia Treatment Market Analysis & Key Trends 2025
Sarcopenia which results in the decrease of lean muscle mass when the person reaches age thirty or above, she or he could expect the gradual loss of muscle tissues due to increasing aging altering the level of activity and also affecting the quality of life. Aging leads to change in metabolic activity which includes the decrease in synthesis of muscle protein and little change in the degradation. Sarcopenia affects
Sarcopenia Pipeline Review H2 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Pipeline Review, H2 2017, provides an overview of the Sarcopenia (Musculoskeletal Disorders) pipeline landscape. Sarcopenia is defined as the loss of mass and muscular function with age. Symptoms include obesity, difficulty walking or moving about, lack of strength and respiratory problems. Treatment includes medications and hormone replacement therapy. Publisher's Pharmaceutical and Healthcare latest pipeline guide Sarcopenia - Pipeline Review, H2 2017,
Sarcopenia Treatment Market: Upcoming Demands and Growth Analysis 2025
Sarcopenia is the loss of muscle mass and muscle strength as a person reaches age thirty or more, in response to aging, affecting the level of activity and quality of life. It has been identified in three stages in older people: presarcopenia-loss of muscle mass, sarcopenia-loss of muscle which can affect either physical performance or physical strength, and severe sarcopenia-loss of muscle mass that affects both physical performance and strength.